School of Psychology, University of New South Wales, Sydney, NSW, 2052, Australia.
Clinical, Neuro and Developmental Psychology, VU University, Amsterdam, The Netherlands.
BMC Public Health. 2020 Mar 26;20(1):390. doi: 10.1186/s12889-020-08463-5.
Accessing quality mental health care poses significant challenges for persons affected by adversity, especially in low- and middle-income countries where resources are scarce. To mitigate this, the World Health Organization has developed group problem management plus (gPM+), a low-intensity psychological intervention for adults experiencing psychological distress. gPM+ is a group-based intervention consisting of five-sessions, and can be delivered by non-specialist providers. This paper outlines the study protocol for a trial of gPM+ in Jordan.
We will conduct a single-blind, two-arm, randomized controlled trial in a Syrian refugee camp in Jordan. We aim to enrol 480 adults into the trial. Participants will be eligible for the trial if they screen positive for levels of psychological distress. Following screening, those eligible will be randomly assigned to receive the gPM+ intervention or enhanced treatment as usual. The primary outcome is reduction in levels of psychological distress at 3-months post-treatment. Secondary outcomes include anxiety, depression, prodromal psychotic symptoms, posttraumatic stress disorder, prolonged grief, daily functioning, economic effectiveness, and change in parenting behaviour. Secondary outcomes also include the reduction in psychological distress of the participant's child.
The trial aims to deliver a template for affordable and scalable psychosocial interventions that can readily be implemented in refugee settings, and that can benefit both the participant and their child.
Australian New Zealand Clinical Trials Registry, ACTRN12619001386123. Registered prospectively on 10/10/2019.
对于处于困境中的人来说，获得高质量的心理健康护理存在重大挑战，特别是在资源匮乏的中低收入国家。为了解决这一问题，世界卫生组织开发了团体问题管理加（gPM+），这是一种针对经历心理困扰的成年人的低强度心理干预措施。gPM+是一种基于团体的干预措施，包括五节课程，可以由非专业人员提供。本文概述了在约旦对 gPM+进行试验的研究方案。
我们将在约旦的一个叙利亚难民营中进行一项单盲、两臂、随机对照试验。我们的目标是将 480 名成年人纳入试验。如果参与者对心理困扰的水平进行筛查呈阳性，则有资格参加试验。筛选后，符合条件的人将被随机分配接受 gPM+干预或增强的常规治疗。主要结果是治疗后 3 个月时心理困扰程度的降低。次要结果包括焦虑、抑郁、前驱精神病症状、创伤后应激障碍、长期悲伤、日常功能、经济效果以及育儿行为的改变。次要结果还包括参与者的孩子的心理困扰程度的降低。
该试验旨在提供一种负担得起且可扩展的心理社会干预模板，可在难民环境中轻松实施，并使参与者及其孩子受益。
澳大利亚新西兰临床试验注册中心，ACTRN12619001386123。于 2019 年 10 月 10 日前瞻性注册。
